Company: ICUI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000883984-25-000007
Chunk: 374

Company: ICU MEDICAL INC/DE
Filing Date: 2025-02-27
Form: 10-K
Item: Item 8
Chunk 374
---
,026)21.0 %State income tax, net of federal effect701 (1.1)%(6,057)7.7 %(5,050)4.4 %Tax credits(10,985)16.6 %(9,824)12.5 %(3,636)3.2 %Global intangible low-taxed income2,977 (4.5)%(2,658)3.4 %2,303 (2.0)%Foreign income tax differential(4,231)6.4 %(2,506)3.2 %(2,943)2.5 %Stock-based compensation2,824 (4.3)%(289)0.4 %(3,721)3.2 %Foreign-derived intangible income(3,756)5.7 %(3,299)4.2 %(2,269)2.0 %Transaction cost— — %— — %2,299 (2.0)%Contingent consideration(838)1.3 %(3,407)4.4 %(6,830)6.0 %Section 162(m)1,880 (2.8)%3,268 (4.2)%3,942 (3.4)%Tax reserve releases(2,216)3.3 %(6,884)8.8 %(1,834)1.6 %Legal Settlement(2,100)3.2 %— — %— — %Valuation allowance81,713 (123.8)%— — %— — %Other(431)0.7 %(545)0.7 %1,642 (1.4)% $51,676 (78.3)%$(48,644)62.1 %$(40,123)35.1 % Tax credits in 2024, 2023 and 2022 consist principally of research and developmental tax credits. The components of our deferred income tax assets (liabilities) are as follows (in thousands):As of December 31, 20242023Deferred tax asset:  Accruals/other$40,849 $30,190 Acquired future tax deductions7,869 10,877 Stock-based compensation3,940 6